Latest Dentsply International Inc (XRAY) Headlines
Post# of 53
DENTSPLY International Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:30PM CDT
Positive earnings guidance and anticipated improvement in the global market conditions in 2014, combined with improving leveraged position and margins, represent a potential upside for DENTSPLY going forward.
Dental Prosthetic Supplies - Global Strategic Business Report: Forecasts up to 2018
M2 - Mon Mar 10, 11:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/svvfnz/dental_prosthetic) has announced the addition of the "Dental Prosthetic Supplies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Dental Prosthetic Supplies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 99 companies including many key and niche players such as 3M ESPE AG, Coltene/Whaledent AG, DenMat Holdings, LLC, DENTSPLY International, Inc., DeguDent GmbH, DMG GmbH, GC Corporation, Heraeus Kulzer GmbH, Institut Straumann AG, Ivoclar Vivadent AG, WIELAND Dental + Technik GmbH & Co. KG, Kuraray Noritake Dental, Inc., Nobel Biocare Holding AG, Shofu, Inc., Sybron Dental Specialties, Kerr Corporation, and VOCO GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II.EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. NOTEWORTHY TRENDS & ISSUES 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/sv...prosthetic About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Post Earnings Update: DENTSPLY International Has Climbed 2.6% Higher in Past 2 Weeks (XRAY)
Comtex SmarTrend(R) - Mon Mar 10, 7:57AM CDT
When DENTSPLY International (NASDAQ:XRAY) reported earnings two weeks ago on February 18th, 2014, analysts, on average, expected the company to report earnings of $0.61 on sales of $767.8 million. The company actually reported EPS of $0.61 on sales of $753.7 million, matching EPS estimates and missing revenue estimates by $14.1 million. Shares of DENTSPLY International have climbed from $45.69 to $46.86, representing a gain of 2.6% since the company reported earnings 20 days ago.
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare
PR Newswire - Thu Mar 06, 10:50AM CST
Today, Analysts Review released its analysts' notes regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), DENTSPLY International Inc. (NASDAQ: XRAY), AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), Cadence Pharmaceuticals Inc. (NASDAQ: CADX), and ArthroCare Corporation (NASDAQ: ARTC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
DENTSPLY International Inc. to Present at the 2014 Barclays Global Healthcare Conference
Thomson Reuters ONE - Tue Mar 04, 5:19PM CST
York, PA - March 4, 2014 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Chris Clark, President and Chief Financial Officer, will be presenting at the 2014 Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida on Thursday March 13, 2014.
Form 4: Update Filing for Snyder's-Lance Inc (LNCE)
Vickers Stock Research - Wed Feb 26, 10:03AM CST
York, PA - February 26, 2013 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that its Board of Directors declared a quarterly cash dividend of $0.0625 per share of common stock, an indicated annual rate of $0.25 per share. This represents an increase of 13.6% from the prior annual rate of $0.22 per share. The dividend is payable on April 12, 2013 to holders of record on March 29, 2013.
DENTSPLY Implants Expands Digital Solutions with Intraoral Scanning for ATLANTIS(TM) Abutments
Business Wire - Thu Feb 20, 7:00AM CST
DENTSPLY Implants expands further into the area of digital dentistry with intraoral scanning services for ATLANTIS abutments, the latest business development that will provide dental clinics and dental laboratories with an improved digital workflow.
North America Dental Implants Market 2014-2018: Biomet 3i, Dentsply, Nobel Biocare & Straumann Holding Dominate the Industry
M2 - Wed Feb 19, 10:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/lgrnzk/dental_implants) has announced the addition of the "North America Dental Implants Market 2014-2018: Biomet 3i, Dentsply, Nobel Biocare & Straumann Holding Dominate the Industry" report to their offering. Vendors in the Dental Implants market in North America are adopting product bundling strategies, where two or more products or services are combined together to achieve product differentiation and to provide better product offerings. Moreover, patients opt for packaged offerings as opposed to individual products because they are cost effective. For instance, manufacturers are providing complementary products along with dental implants such as dental biomaterials, CAD/CAM, crowns and bridges to become a one-stop shop and to leverage their reputation in the implant business. This marketing strategy has helped several vendors to gain a competitive advantage over other vendors. This trend is expected to have a strong impact on the market in the future. According to the report, one of the major drivers in this market is the steady increase in edentulous population worldwide, which is more susceptible to dental problems, propelling the growth of the market. Further, the report states that one of the major challenges is the high cost of customized dental implants which is difficult for people to afford. Market Shares and SWOT Analysis for these vendors: - Biomet 3i - DENTSPLY International Inc. - Nobel Biocare Holding AG - Straumann Holding AG Five Force Model Impact Analysis of: - Suppliers - Buyers - Substitutes - New entrants - Market competition Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Material 08. Market Segmentation by Procedure 09. Market Segmentation by Stages 10. Market Segmentation by Connectors 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/lg...l_implants
DENTSPLY International Q4 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 3:05AM CST
For full year 2013, adjusted net earnings per share rose 5.9% to $2.35 from $2.22 a year ago and were in line with the Zacks Consensus Estimate.
DENTSPLY International Reports Fourth Quarter and Fiscal 2013 Results
Thomson Reuters ONE - Tue Feb 18, 6:00AM CST
- Fiscal 2013 adjusted earnings per diluted share grew 6% to $2.35
DENTSPLY International Inc. to Present at the Citi 2014 Global Healthcare Conference
Thomson Reuters ONE - Fri Feb 14, 2:26PM CST
York, PA - February 14, 2014 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Chris Clark, President and Chief Financial Officer, will be presenting at Citi's 2014 Global Healthcare Conference at the Hilton New York Hotel in New York City on Monday, February 24, 2014.
Global Dental Market Report: 2013 Edition
M2 - Thu Feb 13, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/vmcsc3/global_dental) has announced the addition of the "Global Dental Market Report: 2013 Edition" report to their offering. Dentistry is the branch of science devoted for maintenance and treatment of teeth, gums, and other soft and hard tissues of oral cavity and adjacent structures. Dental market is bifurcated into two segments: dental consumables and dental equipments. Dental consumables represent the larger segment of the dental care industry. The dental consumables segment includes crowns/bridges, implants, orthodontics, impressive materials, composites, endodontics, adhesives, and cements, while the dental equipment segment is composed of large equipment, such as autoclaves, sterilizers, chairs, communication systems, compressors, cuspidors, and digital imaging systems. Small equipment, including amalgam removal systems, amalgamators, hand piece cleaners, lab equipment, duplicators, and ultrasonic cleaners, also fall into this product segment. The main drivers of the global dental market include low dental implant penetration rates and increasing elderly population. Global economic development and increasing consumer income are other major factors which are bolstering the dental market. Ongoing mergers and acquisitions, increasing prevalence of CAD/CAM technology and increasing share of emerging markets are the significant trends observed in the dental market. This report analyzes the development of the "global dental market", with a focus on its segments including: dental consumables and dental equipment. The major market of North America along with emerging market of China is being discussed in the report. The major trends, drivers facilitating growth of the dental market as well as the issues being faced by the industry are being presented in this report. The four major players in the dental industry, Nobel Biocare, Straumann, Dentsply and Zimmer are being profiled in the report highlighting their key financials and strategies for growth. Key Topics Covered 1. Overview 1.1 Dental Diseases 1.2 Dental Treatment 1.3 Dental Market Segments 2. Global Dental Market 2.1 North American Dental Market 2.2 China 3. Market Dynamics 3.1 Key Trends 3.2 Growth Drivers 3.3 Challenges 4. Competitive Landscape 4.1 North America 4.2 China 5. Company Profiles 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology Companies Mentioned - DENTSPLY International - Nobel Biocare - Straumann - Zimmer For more information visit http://www.researchandmarkets.com/research/vm...bal_dental About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
DENTSPLY International Schedules Fourth Quarter and Fiscal 2013 Earnings Release and Conference Call
Thomson Reuters ONE - Tue Feb 04, 4:13PM CST
York, PA - February 4, 2014 - DENTSPLY International Inc. (NASDAQ: XRAY) announced that it will release its fourth quarter 2013 earnings results on Tuesday, February 18, 2014 at approximately 7:00 a.m. (Eastern Time). Following the press release, the Company will host a conference call with a live webcast to discuss its financial results. Supplemental materials for reference during the call will be available for download in the investor relations section of DENTSPLY's web site, at www.dentsply.com.
Best's Rating Notification - Lincoln Benefit Life Company
Rating Division - AMBest - Fri Jan 31, 1:44PM CST
A.M. Best Company has made the following rating update:
DENTSPLY International Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Fri Jan 10, 7:40AM CST
York, PA - January 10, 2014 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, and Chris Clark, President and Chief Financial Officer, will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on Tuesday, January 14, 2014.
Clinical Study Updates, Milestones Achievements, and Stock Price Movements - Research Report on Johnson & Johnson, Epizyme, Health Management, DENTSPLY, and Charles River
PR Newswire - Fri Jan 10, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Epizyme Inc. (NASDAQ: EPZM), Health Management Associates Inc. (NYSE: HMA), DENTSPLY International Inc. (NASDAQ: XRAY) and Charles River Laboratories (NYSE: CRL). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Align Technology, Inc.: The Best Medical Device Companies of 2013
Todd Campbell, The Motley Fool - Motley Fool - Thu Jan 09, 5:14PM CST
With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry performed well in 2013 -- but which stocks were the biggest winners? Some of the best performers outpaced the index significantly last...
Form 4: Update Filing for First Solar Inc (FSLR)
Vickers Stock Research - Sat Jan 04, 9:11AM CST
York, PA - January 4, 2013 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, will be presenting at the 31st Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 7, 2013.
Becton, Dickinson Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 9:20AM CST
Shares of BDX closed at $110.49 on the same day, representing a solid one-year return of 44.3%.
Technical Stock Coverage for the Day:VIVUS, Sanofi, Healthways, and DENTSPLY Intl.
PR Newswire - Fri Dec 27, 7:00AM CST
On Thursday, December 26, 2013, the U.S. equity market edged higher as the S&P 500 ended the day at 1,842.02, up 0.47%; the Dow Jones Industrial Average closed at 16,479.88, up 0.75%; and the NASDAQ Composite Index finished at 4,167.18, up 0.28%. The S&P 500 Health Care Sector Index edged 0.67% higher to close at 642.32; and the same has gained 1.00% in the previous three trading sessions and 9.72% in the last three months, compared to a gain of 1.30% and 8.82% in the S&P 500, during the respective periods. The major movers in the Health Care Sector included VIVUS Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY), Healthways Inc. (NASDAQ: HWAY), and DENTSPLY International Inc. (NASDAQ: XRAY). AAAResearchReports.com has completed their technical analysis on VVUS, SNY, HWAY, and XRAY and these free reports are accessible by registering at: